Why PEPFAR's top scientist stepped down

Mike Reid, the former chief science officer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), resigned amid growing concerns about the direction of America’s global health strategy. Reid cited a fundamental conflict between U.S. foreign policy and global health goals, particularly the increasing tendency to tie lifesaving health services to broader commercial and political agreements. He expressed unease that access to critical HIV treatments and prevention efforts could be compromised if the U.S. government prioritized securing economic or strategic benefits from partner countries. Reid’s departure highlights tensions within PEPFAR and U.S. global health initiatives as the Trump administration restructured foreign aid, shifting from traditional multilateral support through agencies like USAID to direct bilateral agreements. This shift raised fears that health aid might be used as leverage for unrelated negotiations, such as mineral rights or other commercial interests, potentially jeopardizing vulnerable populations’ access to care. Reid emphasized that while global health programs often serve as instruments of soft power, the recent policy changes risk undermining the humanitarian mission that has sustained PEPFAR’s success for over two decades. Recent PEPFAR data from 2024 revealed a troubling decline in HIV testing and prevention services, although treatment retention remains relatively stable in many countries. Reid and other global health experts are particularly concerned about the uneven impact of these declines, as HIV disproportionately affects marginalized communities. Reduced testing and prevention could lead to increased transmission rates and worsen health disparities, undermining progress made in controlling the epidemic. Reid’s resignation serves as a critical warning about the potential consequences of intertwining global health aid with broader geopolitical and economic agendas. It raises important questions about the sustainability and ethical framework of U.S. foreign health assistance, especially as the world continues to grapple with persistent infectious diseases and health inequities.